SCHEMBL4040587

SCHEMBL4040587

Cn1c(N)nnc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9176037 0.78
SCHEMBL11469968 0.76
SCHEMBL10402132 0.69
SCHEMBL390752 0.69
SCHEMBL5498042 0.67
SCHEMBL13865681 0.67
SCHEMBL9642497 0.65 TLR8 (0.42)
SCHEMBL25440344 0.63
SCHEMBL391856 0.63 LMNA (0.36)
SCHEMBL392223 0.63 MEN1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP claimed
US-20060100431-A1 Biologically active compounds AMURA THERAPEUTICS LIMITED (GB) 2006-05-11 US claimed
WO-2024043032-A1 CONDUCTIVE SUBSTRATE AND TOUCH PANEL 富士フイルム株式会社 2024-02-29 WO disclosed
WO-2023228927-A1 CONDUCTIVE SUBSTRATE AND TOUCH PANEL 富士フイルム株式会社 2023-11-30 WO disclosed
EP-3279188-B1 AXIALLY CHIRAL ISOMERS, AND PREPARATION METHODS THEREFOR AND PHARMACEUTICAL USES THEREOF MEDSHINE DISCOVERY INC (CN) 2020-09-09 EP disclosed
US-10351537-B2 Processes for the preparation of lesinurad and intermediates thereof APOTEX INC. (CA) 2019-07-16 US disclosed
US-20190142805-A1 Novel Compounds and Compositions and Methods of Use ARDEA BIOSCIENCES INC. 2019-05-16 US disclosed
US-7880950-B2 low drive voltage, high display contrast, high reflectance and small variation of the reflectance of white display; exhibiting a decreased color change in white display after repeated driving operation of the display element KONICA MINOLTA HOLDINGS, INC. (JP) 2011-02-01 US disclosed
US-7880950-B2 low drive voltage, high display contrast, high reflectance and small variation of the reflectance of white display; exhibiting a decreased color change in white display after repeated driving operation of the display element KONICA MINOLTA HOLDINGS, INC. (JP) 2011-02-01 US disclosed
US-20090243462-A1 DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2009-10-01 US disclosed
US-20090243462-A1 DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2009-10-01 US disclosed
US-7332265-B2 Silver halide color photographic light-sensitive material, and image-forming method FUJIFILM CORPORATION (JP) 2008-02-19 US disclosed
US-7332265-B2 Silver halide color photographic light-sensitive material, and image-forming method FUJIFILM CORPORATION (JP) 2008-02-19 US disclosed
US-6579892-B1 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole ABBOTT LABORATORIES 2003-06-17 US disclosed
CN-1021910-C LANKACIDIN DERIVATIVES AND PRODUCTION THEREOF TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1993-08-25 CN disclosed
US-4914206-A ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-04-03 US disclosed
US-4804623-A ANTIFOGGING AGENTS AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) 1989-02-14 US disclosed
CN-86108176-A Lankacidin derivatives and process for producing the same 1987-10-21 CN disclosed
US-4264721-A AN ACYLAMIDE YELLOW COUPLER AND A 5-THIA-1,2,4-TRIAZOLE KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1981-04-28 US disclosed
US-4144391-A REPLACING AN ACETOXY GROUP BY A SULFUR NUCLEOPHILE ELI LILLY AND COMPANY (US) 1979-03-13 US disclosed